HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperthyroxinemia in patients treated with high-dose propranolol.

Abstract
Six patients with hyperthyroxinemia (five men and one woman) were evaluated for possible hyperthyroidism. All were taking large daily doses of propranolol--480 +/- 155 (+/- SE) mg--for treatment of angina pectoris. The patients had no clinical evidence of hyperthyroidism, although three had small goiters. Further evaluation of the patients revealed elevated serum free thyroxine levels and/or free thyroxine index, low-normal serum triiodothyronine levels, and elevated serum reverse triiodothyronine levels in all six. The thyroid-stimulating hormone response to thyrotropin-releasing hormone was normal in two patients, subnormal in three patients, and absent in one patient. One patient was restudied while receiving low-dose propranolol (80 mg a day), with normalization of all thyroid functional parameters. The data suggest that the abnormalities seen in patients taking high doses of propranolol were due to drug-induced blockade of iodothyronine deiodination. Signs and symptoms of hyperthyroidism are lacking in patients taking large doses of propranolol. If such a patient is discovered to have an elevated serum thyroxine level, a more complete evaluation of thyroid function is necessary before the diagnosis of thyrotoxicosis can be made. The thyrotropin-releasing hormone test may be of particular value in this circumstance.
AuthorsD S Cooper, G H Daniels, P W Ladenson, E C Ridgway
JournalThe American journal of medicine (Am J Med) Vol. 73 Issue 6 Pg. 867-71 (Dec 1982) ISSN: 0002-9343 [Print] United States
PMID6816067 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Triiodothyronine
  • Triiodothyronine, Reverse
  • Thyrotropin-Releasing Hormone
  • Propranolol
  • Thyroxine
Topics
  • Aged
  • Angina Pectoris (drug therapy)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Propranolol (adverse effects, therapeutic use)
  • Thyrotropin-Releasing Hormone (blood)
  • Thyroxine (blood)
  • Triiodothyronine (blood)
  • Triiodothyronine, Reverse (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: